Literature DB >> 30633153

Posterior reversible encephalopathy syndrome with spinal cord involvement but without hemisphere lesions: A case report.

Lu Liu1, Dawei Dai, Fan Cao, Liming Zhang, Xun Wang.   

Abstract

RATIONALE: Posterior reversible encephalopathy syndrome (PRES) was termed by Hinchey in 1996. Patients have a reversible vasogenic brain edema in imaging and acute neurological symptoms such as headache, seizures, encephalopathy, and visual disturbances when suffering from hypertension, pre-eclampsia/eclampsia, renal failure, immunosuppressive medications, autoimmune disorders, sepsis, thrombocytopaenia, hypocalcaemia, alcohol withdrawal, and many other potential causes. de Havenon A et al have proposed a new syndrome named PRES with spinal cord involvement (PRES-SCI). The patients with PRES-SCI have similar symptoms these of PRES. Patients have neurologic signs with the spinal cord involved and lesions in magnetic resonance imaging (MRI) extending to the cervicomedullary junction, usually with extreme elevation in blood pressure and a history of hypertensive retinopathy. We administrated a young patient whose condition was consistent with PRES-SCI except for the hemisphere lesions. PATIENT CONCERNS: A 20-year-old Asian male patient was admitted for a 1 week history of blurred vision and weakness of the limbs. He has had poorly controlled hypertension for 1 year before admission. In emergency room, his blood pressure could raise to 260/140mmHg. Neurological examinations and cerebral spinal fluid tests were negative. The MRI of the brain and spinal cord showed reversible lesions in the medulla and upper cervical spinal cord that extended to the lower thoracic spine. DIAGNOSIS: Taking into account the characteristic lesions in the MRI as well as the reversible course upon treatment, he was diagnosed PRES-SCI.
INTERVENTIONS: He was treated with medicines for the hypertension. OUTCOMES: His symptoms rapidly improved and finally the lesions on the MRI of the brain and spianl cord disappeared. LESSONS: Clinicians should suspect PRES-SCI when patients have mild or no neurologic signs accompanied with extreme elevation in blood pressure and lesions in spinal cord. Spinal lesions alone may be a subtype of PRES-SCI.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30633153      PMCID: PMC6336622          DOI: 10.1097/MD.0000000000013649

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


Introduction

Posterior reversible encephalopathy syndrome (PRES) was termed by Hinchey et al[ in 1996. Patients with PRES have a reversible vasogenic brain edema in imaging and acute neurological symptoms such as headache, seizures, encephalopathy, and visual disturbances while suffering from hypertension, pre-eclampsia/eclampsia, renal failure, immunosuppressive medications, autoimmune disorders, sepsis, thrombocytopaenia, hypocalcaemia, alcohol withdrawal, and many other potential causes.[ The magnetic resonance imaging (MRI) findings corresponding to edema are classically located in parieto-occipital lobes, but often the frontal and temporal lobes, basal ganglia, cerebellum, and brainstem are also involved.[ Thanks to advanced and more readily available imaging modalities, PRES is becoming increasingly diagnosed. de Havenon A et al[ has proposed a new syndrome named PRES with spinal cord involvement (PRES-SCI). Patients with PRES-SCI have similar symptoms these of PRES. Patients have neurologic signs with the spinal cord involved and lesions in MRI extending to the cervicomedullary junction, usually with extreme elevation in blood pressure and a history of hypertensive retinopathy.[ The lesions can be located in the brain or the spinal cord or both. We report a young patient whose condition was consistent with PRES-SCI but without the hemisphere lesions.

Case description

An appropriate written informed consent was obtained from the patient reported in this study.

Patient information

This 20-year-old Asian male patient was admitted for a 1 week history of blurred vision, abrupt headache, and weakness of the limbs. He has had poorly controlled hypertension for 1 year and mild kidney disease for about 1 month. His blood pressure is usually between 210/110 and 220/120mm Hg.

Clinical findings

In the emergency room, his blood pressure rose to 260/140mm Hg. Neurological examinations did not find any positive symptoms. Immunological blood tests were normal. Non-enhanced computed tomography (CT) showed no evidence of cerebral hemorrhage or subarachnoid hemorrhage. Magnetic resonance imaging (MRI) of the brain (Fig. 1A(A1, A2)) on the admission showed that there were no lesions in either hemisphere, though MRI of the spinal cord on admission (Fig. 1B) and the third day (Fig. 1C) showed T2- weighted images and fluid-attenuated inversion recovery (FLAIR) hyperintensity in the medulla, and upper cervical spinal cord that extended to the lower thoracic spine. Scanning laser ophthalmoscope examination showed hypertension related retinopathy in both eyes (Fig. 1E-F). A lumbar puncture had normal opening pressure, unremarkable cell indices, and no evidence of demyelination.
Figure 1

Characteristic imaging findings in PRES-SCI without hemisphere lesions involved. (A) Axial FLAIR of hemisphere and T2 of medullar. (A1, A2) There was no hyperintensity of the bilateral parietal and occipital lobes in FLAIR brain MRI. (A3) Hyperintensity of the brain only limited in the medully in T2. (B) Axial FLAIR hyperintensity of the medulla, and sagittal T2 hyperintensity in upper cervical spinal cord extending to the lower thoracic spine on admission. (C, D) follow-up MRI on the 3rd (C) and 10th (D) day of the spinal cord. Sagittal T2 of the medulla and cervical spinal cord after admission shows resolution of the prior hyperintensity (compare to A3and B), which was also true on the thoracic spine MRI (not shown). (E, F), Scanning Laser Ophthalmoscope examination showed hypertension related retinopathy in both eyes (E, left; F right). Fundus photograph of the eyes shows optic nerve edema, macular star pattern of exudates in the macula, and cotton-wool spots and flame hemorrhages. MRI = magnetic resonance imaging, PRES-SCI = posterior reversible encephalopathy syndrome with spinal cord involvement.

Characteristic imaging findings in PRES-SCI without hemisphere lesions involved. (A) Axial FLAIR of hemisphere and T2 of medullar. (A1, A2) There was no hyperintensity of the bilateral parietal and occipital lobes in FLAIR brain MRI. (A3) Hyperintensity of the brain only limited in the medully in T2. (B) Axial FLAIR hyperintensity of the medulla, and sagittal T2 hyperintensity in upper cervical spinal cord extending to the lower thoracic spine on admission. (C, D) follow-up MRI on the 3rd (C) and 10th (D) day of the spinal cord. Sagittal T2 of the medulla and cervical spinal cord after admission shows resolution of the prior hyperintensity (compare to A3and B), which was also true on the thoracic spine MRI (not shown). (E, F), Scanning Laser Ophthalmoscope examination showed hypertension related retinopathy in both eyes (E, left; F right). Fundus photograph of the eyes shows optic nerve edema, macular star pattern of exudates in the macula, and cotton-wool spots and flame hemorrhages. MRI = magnetic resonance imaging, PRES-SCI = posterior reversible encephalopathy syndrome with spinal cord involvement.

Diagnostic assessment

After management of blood pressure, his symptoms rapidly improved. Taking into account the characteristic lesions in the MRI as well as the reversible course upon treatment, he was diagnosed PRES-SCI.

Therapeutic interventions

He was treated with Valsartan (40 mg per day) and Amlodipine Tablets (I) (Novartis Pharma Stein AG, Switzerland) (5 mg per day) for the hypertension, his symptoms rapidly improved. Ten days after admission, a follow-up MRI of the spinal cord showed disappearance of previous imaging finding in T2-weighted image in the medulla and spinal cord (Fig. 1D). Considering the characteristics of clinical and imaging performance, an atypical variant of PRES was the most plausible diagnosis. One year after being discharged from hospital, the patient remained asymptomatic.

Discussion

Posterior reversible encephalopathy syndrome with spinal cord involvement (PRES-SCI) was 1st proposed by de Havenon A et al[. The PRES-SCI is considered as a unique disorder which affects the spinal cord and classically displays posterior hemispheric lesions and is thought to be a subtype of PRES. The PRES-SCI is very rare and usually seen in young male patients with severe acute hypertension that clinically manifests as headache, nausea/vomiting, visual disturbance, and hypertensive retinopathy, renal failure, but not necessarily seizure.[ The most frequently proposed mechanism of PRES is a failure of posterior circulation autoregulation in severe hypertension which break through the normal cerebral blood flow.[ The vertebrobasilar system is considered particularly sensitive to the sudden change of blood pressure due to the reduced innervation of sympathetic nerves. The anterior spinal artery arises from the vertebrobasilar system, which may explain our patient's lesions in the cervical cord. The prognosis of PRES is mainly decided by the underlying condition, since most neurological symptoms are reversible in the majority of patients.[ Patients diagnosed with PRES-SCI usually have good prognosis and typically resolve within a few weeks after appropriate treatment. Appropriate reduction of blood pressure may prevent lesion progression from vasogenic edema into cytotoxic oedema, infarction or even permanent neurological deficits.[ Unlike other classical PRES cases, which have lesions involving posterior structures of the brain, posterior hemisphere lesions including bilateral occipital lobes were not involved in this patient. Compared with clinical manifestation of PRES-SCI, the course which usually lasts more than 2 weeks was much shorter and imaging change was rather faster. In this case the patient's symptom resolved within a few days after gradually controlling his blood pressure and MRI lesions disappeared within 10 days. We followed up him for a year and he had no complaints. We think hemisphere lesions such as parietal or occipital location were not necessary for the clinical manifestation and diagnosis of PRES-SCI. Although rare but spinal lesions alone may indicate a subtype of PRES-SCI. Clinicians should suspect PRES-SCI when patients have mild or no neurologic signs accompanied with extreme elevation in blood pressure and lesions in the spinal cord. Spinal lesions alone may indicate a subtype of PRES-SCI. As this subtype also includes the spinal cord lesions, when considering PRES-SCI, which, if diagnosed, would spare patients the morbidity of a standard myelitis workup and empiric treatment.[ We found and diagnosed an unusual case of PRES-SCI clearly. However, since we have only 1 patient of this subtype, there is little opportunity to do further analysis.

Author contributions

Conceptualization: Liming Zhang. Data curation: Xun Wang. Investigation: Dawei Dai. Resources: Fan Cao. Supervision: Xun Wang. Writing – original draft: Lu Liu.
  10 in total

1.  Spinal cord involvement during hypertensive encephalopathy: clinical and radiological findings.

Authors:  Antonio Milia; J Moller; G Pilia; M G Mascia; P Marchi; M Mura; M G Marrosu
Journal:  J Neurol       Date:  2008-01-18       Impact factor: 4.849

Review 2.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

3.  Posterior reversible encephalopathy syndrome with involvement of the cervical cord and medulla: a case report.

Authors:  Xuan Hou; Jinfeng Xu; Zao Chen; Gguoliang Li; Hong Jiang
Journal:  J Clin Diagn Res       Date:  2015-01-01

Review 4.  Posterior reversible encephalopathy syndrome--Insight into pathogenesis, clinical variants and treatment approaches.

Authors:  Guido Granata; Antonio Greco; Giannicola Iannella; Massimo Granata; Alessandra Manno; Ersilia Savastano; Giuseppe Magliulo
Journal:  Autoimmun Rev       Date:  2015-05-18       Impact factor: 9.754

5.  Posterior reversible encephalopathy syndrome and eclampsia: pressing the case for more aggressive blood pressure control.

Authors:  Steven J Wagner; Letitia A Acquah; E Paul Lindell; Iasmina M Craici; Majken T Wingo; Carl H Rose; Wendy M White; Phyllis August; Vesna D Garovic
Journal:  Mayo Clin Proc       Date:  2011-09       Impact factor: 7.616

6.  Posterior reversible encephalopathy syndrome with spinal cord involvement.

Authors:  Adam de Havenon; Zachary Joos; Loren Longenecker; Lubdha Shah; Safdar Ansari; Kathleen Digre
Journal:  Neurology       Date:  2014-10-29       Impact factor: 9.910

7.  Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome.

Authors:  W S Bartynski; J F Boardman
Journal:  AJNR Am J Neuroradiol       Date:  2007-12-13       Impact factor: 3.825

8.  Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings.

Authors:  Alexander M McKinney; James Short; Charles L Truwit; Zeke J McKinney; Osman S Kozak; Karen S SantaCruz; Mehmet Teksam
Journal:  AJR Am J Roentgenol       Date:  2007-10       Impact factor: 3.959

9.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

10.  Involvement of the cervical cord and medulla in posterior reversible encephalopathy syndrome.

Authors:  Naseer A Choh; Majid Jehangir; Muddassir Rasheed; Tajamul Mira; Irfan Ahmad; Suhil Choh
Journal:  Ann Saudi Med       Date:  2011 Jan-Feb       Impact factor: 1.526

  10 in total
  1 in total

Review 1.  Posterior Reversible Encephalopathy Syndrome: A Review of the Literature.

Authors:  Yuya Ando; Yosuke Ono; Azusa Sano; Naoya Fujita; Sachiko Ono
Journal:  Intern Med       Date:  2021-07-17       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.